OPTIMER PHARMACEUTICALS INC (OPTR) has 39 open-market insider trades by 12 insiders since 2007. The most active filer is Michael N. Chang, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Alain Schreiber | Dir | — | 1 | $8.0M | 2008-07-18 |
| Pharmacuetical Inc. Par | 10% | — | 1 | $7.3M | 2007-02-21 |
| Pedro Lichtinger | — | — | 3 | $2.5M | 2013-04-08 |
| Tessie M. Che | COO and SVP | — | 8 | $1.7M | 2012-01-01 |
| Michael N. Chang | Dir | — | 9 | $1.7M | 2013-10-24 |
| Perceptive Advisors LLC | 10% | — | 1 | $1.5M | 2008-07-02 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% | — | 1 | $429K | 2007-12-19 |
| Joseph Y. Chang | Dir | — | 2 | $148K | 2013-10-24 |
| Youe Kong Shue | VPClinical Development | — | 5 | $81K | 2011-11-15 |
| Anthony E. Altig | Dir | — | 1 | $37K | 2013-10-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Pedro Lichtinger | — | Sell | $2.2M | 2013-04-08 |
| Pedro Lichtinger | President | Buy | $100K | 2012-11-08 |
| Joseph Y. Chang | Director | Sell | $53K | 2012-06-11 |
| Anthony E. Altig | Director | Buy | $37K | 2011-08-09 |
| Pedro Lichtinger | President | Buy | $225K | 2011-08-04 |
| Joseph Y. Chang | Director | Sell | $95K | 2010-05-12 |
Companies that share insiders with OPTR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Tessie M. Che | COO and SVP | Buy | $195K | 2009-12-28 |
| Youe Kong Shue | VP & Clinical Development | Buy | $33K | 2009-12-01 |
| Michael N. Chang | President | Buy | $173K | 2009-11-25 |
| John D. Prunty | CFO and VP & Finance | Buy | $12K | 2008-11-17 |
| Kevin P. Poulos | Chief Commercial Officer | Buy | $8K | 2008-11-17 |
| Youe Kong Shue | VP Clinical Development | Buy | $10K | 2008-11-17 |
| Alain Schreiber | Director | Buy | $8.0M | 2008-07-18 |
| Perceptive Advisors LLC | 10% | Sell | $1.5M | 2008-07-02 |
| Tessie M. Che | COO and SVP | Buy | $35K | 2008-06-13 |